Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy

[1]  Siddharth Singh,et al.  Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. , 2019, The Cochrane database of systematic reviews.

[2]  L. A. Christensen,et al.  Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial , 2019, Scandinavian journal of gastroenterology.

[3]  M. Silverberg,et al.  Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. , 2018, Gastrointestinal endoscopy.

[4]  S. Travis,et al.  Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis. , 2017, The Cochrane database of systematic reviews.

[5]  J. Halfvarson,et al.  Changes in medical management and colectomy rates: a population‐based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963‐2010 , 2017, Alimentary pharmacology & therapeutics.

[6]  W. Sandborn,et al.  Development of a core outcome set for clinical trials in inflammatory bowel disease: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey , 2017, BMJ Open.

[7]  M. Mori,et al.  The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis , 2016, Surgery Today.

[8]  G. D'Haens,et al.  Efficient Early Drug Development for Ulcerative Colitis. , 2016, Gastroenterology.

[9]  L. A. Christensen,et al.  Mo1779 Adalimumab in the Treatment of Chronic Pouchitis. A Randomized Double-Blind, Placebo-Controlled Trial , 2016 .

[10]  S. Travis,et al.  Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. , 2016, Journal of Crohn's & colitis.

[11]  S. Travis,et al.  Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials , 2015, Inflammatory bowel diseases.

[12]  A. Zinsmeister,et al.  Cumulative Incidence and Risk Factors for Hospitalization and Surgery in a Population-based Cohort of Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[13]  P. Rutgeerts,et al.  The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. , 2013, Gastroenterology.

[14]  Z. Halpern,et al.  Risk factors for chronic pouchitis after ileal pouch–anal anastomosis: a prospective cohort study , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[15]  Harminder Singh,et al.  The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort , 2012, The American Journal of Gastroenterology.

[16]  G. Kaplan,et al.  Postoperative complications and mortality following colectomy for ulcerative colitis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[18]  Theo Stijnen,et al.  Random effects meta‐analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data , 2010, Statistics in medicine.

[19]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[20]  Steven J Brown,et al.  488 Early Institution of Tinidazole May Prevent Pouchitis Following Ileal-Pouch Anal Anastomosis (IPAA) Surgery in Ulcerative Colitis (UC) Patients , 2010 .

[21]  M. Vatn,et al.  Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) , 2009, Scandinavian journal of gastroenterology.

[22]  S. Leveson,et al.  Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis , 2008, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[23]  P. Tekkis,et al.  Quality of life after indefinite diversion/pouch excision in ileal pouch failure patients , 2007, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[24]  R. Sandler,et al.  Rifaximin for the treatment of active pouchitis: A randomized, double‐blind, placebo‐controlled pilot study , 2007, Inflammatory bowel diseases.

[25]  C. Brensinger,et al.  A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. , 2007, Gastroenterology.

[26]  W. Sandborn,et al.  Systematic review: the management of pouchitis , 2006, Alimentary pharmacology & therapeutics.

[27]  D. Larson,et al.  The Effect of Ageing on Function and Quality of Life in Ileal Pouch Patients: A Single Cohort Experience of 409 Patients With Chronic Ulcerative Colitis , 2004, Annals of surgery.

[28]  Alphonso Brown.  Prophylactic antibiotic use in severe acute pancreatitis: hemlock, help, or hype? , 2004, Gastroenterology.

[29]  M. Kamm,et al.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis , 2003, Gut.

[30]  Elena A. Manilich,et al.  Quantification of Risk for Pouch Failure After Ileal Pouch Anal Anastomosis Surgery , 2003, Annals of surgery.

[31]  J. Connor,et al.  Modified Pouchitis Disease Activity Index , 2003, Diseases of the colon and rectum.

[32]  H. Järvinen,et al.  Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora , 2003, Alimentary pharmacology & therapeutics.

[33]  H. Nagawa,et al.  Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis , 2003, Scandinavian journal of gastroenterology.

[34]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[35]  Theo Stijnen,et al.  Advanced methods in meta‐analysis: multivariate approach and meta‐regression , 2002, Statistics in medicine.

[36]  M. Joelsson, M. Andersson, T. Bark, K. Gullberg, T. H.  Allopurinol as Prophylaxis Against Pouchitis Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Randomized Placebo-controlled Double-blind Study , 2001 .

[37]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[38]  R. Farouk,et al.  Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. , 2000, Annals of surgery.

[39]  P. Brigidi,et al.  Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial , 2000, Gastroenterology.

[40]  R. Farouk,et al.  J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long‐term outcome in 1310 patients , 1998, The British journal of surgery.

[41]  W. Sandborn,et al.  Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double‐blind, placebo‐controlled trial , 1997, Alimentary pharmacology & therapeutics.

[42]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[43]  R. Löfberg,et al.  Pouchitis following pelvic pouch operation for ulcerative colitis , 1996, Diseases of the colon and rectum.

[44]  M. Molinari,et al.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. , 1996, Archives of surgery.

[45]  A. Mcintyre,et al.  Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis , 1994, Digestive diseases and sciences.

[46]  K. Batts,et al.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. , 1994, Mayo Clinic proceedings.

[47]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[48]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[49]  J. Connor,et al.  Modified Pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis , 2003 .

[50]  R. Sjödahl,et al.  Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study. , 2001, Scandinavian journal of gastroenterology.